Evidence map›Paper›PMID 36873179›Full record

ArticleActa pharmaceutica Sinica. B2023

Ze Mi, Qing Yao, Yan Qi, Jinhai Zheng, Jiahao Liu, Zhenguo Liu, Hongpei Tan, Xiaoqian Ma, Wenhu Zhou, Pengfei Rong

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Journal of nanobiotechnology · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ze MiDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Qing YaoDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Yan QiDepartment of Pathology, Shihezi University School of Medicine and the First Affiliated Hospital to Shihezi University School of Medicine, Shihezi 832003, China.
Jinhai ZhengSchool of Biomedical Sciences, Hunan University, Changsha 410082, China.
Jiahao LiuDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Zhenguo LiuDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Hongpei TanDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Xiaoqian MaDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Wenhu ZhouDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Pengfei RongDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Central South University · CNShihezi University · CNHunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy is an important adjuvant treatment of glioma, while the efficacy is far from satisfactory, due not only to the biological barriers of blood‒brain barrier (BBB) and blood‒tumor barrier (BTB) but also to the intrinsic resistance of glioma cells

Indexed as

Blood–brain barrierChemo-sensitizationDoxorubicinGliomaNeutrophil hitchhikingOuter membrane vesiclesP-glycoproteinSalmonella

Identifiers

PMID36873179
PMCPMC9978951
OpenAlexW4297042725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.